Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$55.54 - $72.65 $1.02 Million - $1.33 Million
-18,324 Reduced 42.26%
25,032 $1.65 Million
Q1 2022

Apr 28, 2022

SELL
$24.28 - $56.64 $207,933 - $485,064
-8,564 Reduced 16.49%
43,356 $2.4 Million
Q4 2021

Jan 27, 2022

BUY
$22.54 - $30.44 $1.17 Million - $1.58 Million
51,920 New
51,920 $1.5 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cambiar Investors LLC Portfolio

Follow Cambiar Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.